These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33029257)

  • 1. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
    Ling Y; Tang S; Cao Y; Fu C
    Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of apolipoprotein B and apolipoprotein A1 levels with social determinants of health and coronary artery disease mortality in the United Kingdom Biobank - is there a need for consideration?
    Füller D; Liu C; Desai SR; Vatsa N; Sun YV; Quyyumi AA
    Coron Artery Dis; 2024 Sep; 35(6):509-515. PubMed ID: 38712680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
    Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
    Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.
    van Capelleveen JC; Lee SR; Verbeek R; Kastelein JJP; Wareham NJ; Stroes ESG; Hovingh GK; Khaw KT; Boekholdt SM; Witztum JL; Tsimikas S
    J Clin Lipidol; 2018; 12(6):1493-1501.e11. PubMed ID: 30249512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang Q; Zhang QQ; He JJ; Dong SQ; Lu Y
    Diabetes Res Clin Pract; 2024 Jun; 212():111681. PubMed ID: 38677367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Lp-PLA
    Sairam SG; Sola S; Barooah A; Javvaji SK; Jaipuria J; Venkateshan V; Chelli J; Sanjeevi CB
    Cardiovasc Diagn Ther; 2017 Dec; 7(6):589-597. PubMed ID: 29302464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.
    Tsimikas S; Mallat Z; Talmud PJ; Kastelein JJ; Wareham NJ; Sandhu MS; Miller ER; Benessiano J; Tedgui A; Witztum JL; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2010 Sep; 56(12):946-55. PubMed ID: 20828647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis.
    Khuseyinova N; Imhof A; Rothenbacher D; Trischler G; Kuelb S; Scharnagl H; Maerz W; Brenner H; Koenig W
    Atherosclerosis; 2005 Sep; 182(1):181-8. PubMed ID: 16115490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus.
    Mei Y; Zhao Z; Lyu Y; Li Y
    Lipids Health Dis; 2022 Jul; 21(1):59. PubMed ID: 35842724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.